Accenture, BioCelerate Collaborate on Preclinical Platform

Published on: April 11, 2017

Accenture has announced a collaboration with BioCelerate, a subsidiary of TransCelerate, to develop a platform.

Accenture has announced a collaboration with BioCelerate, a subsidiary of TransCelerate, to develop a platform allowing its member companies to aggregate and analyze preclinical and clinical information in the hopes of improving drug development efficiency.

Read the full release here